Dedicated to Transforming the Way Vascular Disease is Treated
Alucent Biomedical is a privately held biomedical company focused on our vision to transform the way vascular disease is treated. We are focused on using advanced technology to harness the body’s own natural physiologic processes and structures.
Natural Vascular Scaffolding™ (NVS) is a breakthrough technology being developed to address the unmet need of patients with difficult-to-treat peripheral artery disease (PAD). It is the first technology of its kind that uses photoactivated protein linking to potentially restore vessels and provide durable patency without stents or other implants.
Alucent Biomedical was founded by the Avera Research Institute of Avera Health and became a standalone company in 2017.